Surgery or radiation might be used to help prevent or treat symptoms. Median duration of survival without cancer progression was 4.1 months However, the advent of trastuzumab (herceptin) has significantly changed the treatment paradigm of patients.
miladawn - Find @miladawn Onlyfans - Linktree
Learn about what types of her2 positive breast cancer herceptin® (trastuzumab) treats
See full safety and boxed warnings for more information.
An additional nine patients (19%) experienced stable disease for six months or longer
